Evaluation of agonists and antagonists acting at Group I metabotropic glutamate receptors in the thalamus in vivo

Neuropharmacology

Volumn 38, Issue 10, 1999, Pages 1505-1510

  Salt, T E ^a   Turner, J P ^a   Kingston, A E ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

1 aminoindan 1,5 dicarboxylic acid; LY367366; LY367385; LY393053; Metabotropic glutamate receptor antagonist; mGlu1; mGlu5; Thalamus

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; 2 AMINO 2 (3 CARBOXYCYCLOBUTYL) 3 (9 THIOXANTHYL)PROPIONIC ACID; 2 AMINO 2 (4 CARBOXYPHENYL) 3 (9 THIOXANTHYL)PROPIONIC ACID; 4 CARBOXY 2 METHYLPHENYLGLYCINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; RECEPTOR SUBTYPE; THIOXANTHYLMETHYL 3 CARBOXYCYCLOBUTYLGLYCINE; THIOXANTHYLMETHYL 4 CARBOXYPHENYLGLYCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG STRUCTURE; EVOKED RESPONSE; NERVE CELL STIMULATION; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; SOMATOSENSORY STIMULATION; THALAMUS;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; CYCLOLEUCINE; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; METHOXYHYDROXYPHENYLGLYCOL; N-METHYLASPARTATE; NEURONS; PHOSPHOLIPID ETHERS; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; STRUCTURE-ACTIVITY RELATIONSHIP; THALAMUS;

EID: 0032867635     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00081-7     Document Type: Article

References (22)

1. Abe T., Sugihara H., Nawa H., Shigemoto R., Mizuno N., Nakanishi S. Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction. J. Biolog. Chem. 267:1992;13361-13368.
2. Baker S.R., Clark B.P., Harris J.R., Griffey K.I., Kingston A.E., Tizzano J.P. LY393675, an α-substituted-cyclobutylglycine, is a potent Group I metabotropic glutamate receptor antagonist. Soc. Neurosci. Abstr. 28:1998;229.16.
3. Bruno V., Battaglia G., Kingston A.E. et al. Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist (+)-2-methyl-4-carboxyphenylglycine (LY367385): Comparison with LY367366, an antagonist of mGlu1a and mGlu5 receptors. Neuropharmacology. 38:1999;119-207.
4. Clark B.P., Baker S.R., Goldsworthy J., Harris J.R., Kingston A.E. 2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGluR1 receptors. Bioorganic Med. Chem. Lett. 7:1997;2777-2870.
5. Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37:1997;207-237.
6. Contractor A., Gereau R.W., Green T., Heinemann S.F. Direct effects of metabotropic glutamate receptor compounds on native and recombinant N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. USA. 95:1998;8969-8974.
7. Doherty A.J., Palmer M.J., Henley J.M., Collingridge G.L., Jane D.E. (R,S)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5 but not mGlu1 receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology. 36:1997;265-267.
8. Eaton S.A., Birse E.F., Wharton B. et al. Mediation of thalamic sensory responses in vivo by ACPD-activated excitatory amino acid receptors. Eur. J. Neurosci. 5:1993;186-189.
9. Krieger P., Grillner S., El Manira A. Endogenous activation of metabotropic glutamate receptors contributes to burst frequency regulation in the lamprey locomotor network. Eur. J. Neurosci. 10:1998;3333-3342.
10. Martin L.J., Blackstone C.D., Huganir R.L., Price D.L. Cellular localization of a metabotropic glutamate receptor in rat brain. Neuron. 9:1992;259-270.
11. Masu M., Tanabe Y., Tsuchida K., Shigemoto R., Nakanishi S. Sequence and expression of a metabotropic glutamate receptor. Nature. 349:1991;760-765.
12. Moroni F., Lombardi G., Thomsen C. et al. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist. J. Pharmacol. Exp. Ther. 281:1997;721-729.
13. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 258:1992;597-603.
14. Pinkney J.M., Kingston W.P., Thomas N.K., Jane D.E., Pook P.C.-K. Electrophysiological characterisation of (RS)-1-aminoindan-1,5-dicarboxylic acid on the neonatal rat spinal cord preparation. Br. J. Pharmacol. 123:1998;17P.
15. Romano C., Sesma M.A., McDonald C.T., O'Malley K., Van den Pol A.N., Olney J.W. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J. Comp. Neurol. 355:1995;455-469.
16. Romano C., Van den Pol A.N., O'Malley K.L. Enhanced early developmental expression of the metabotropic glutamate receptor mGluR5 in rat brain: protein, mRNA splice variants, and regional distribution. J. Comp. Neurol. 367:1996;403-412.
17. Salt T.E. Excitatory amino acid receptors and synaptic transmission in the rat ventrobasal thalamus. J. Physiol. 391:1987;499-510.
18. Salt T.E., Eaton S.A. Excitatory actions of the metabotropic excitatory amino acid receptor agonist, trans-(±)-1-amino-cyclopentane-1,3-dicarboxylate (t-ACPD), on rat thalamic neurones in vivo. Eur. J. Neurosci. 3:1991;1104-1111.
19. Salt T.E., Eaton S.A. The function of metabotropic excitatory amino acid receptors in synaptic transmission in the thalamus: studies with novel phenylglycine antagonists. Neurochem. Int. 24:1994;451-458.
20. Salt T.E., Turner J.P. Reduction of sensory and metabotropic glutamate receptor responses in the thalamus by the novel mGluR1selective antagonist (S)-2-methyl-4-carboxy-phenylglycine. Neuroscience. 85:1998;655-658.
21. Shigemoto R., Nakanishi S., Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat. J. Comp. Neurol. 322:1992;121-135.
22. Thomas N.K., Woolley M.L., Miller J.C. et al. Novel phenylglycines as metabotropic glutamate receptor antagonists. Soc. Neurosci. Abstr. 28:1998;229.15.